Falls in blood pressure in patients with obstructive sleep apnoea after long-term nasal continuous positive airway pressure treatment
Authors:
- Kazuo ChinKCKazuo Chin
- Takaya NakamuraTNTakaya Nakamura
- Ken-Ichi TakahashiKTKen-Ichi Takahashi
- Kensuke SumiKSKensuke Sumi
- Hisako MatsumotoHMHisako Matsumoto
- Akio NiimiANAkio Niimi
- Shunichi FukuharaSFShunichi Fukuhara
- Michiaki MishimaMMMichiaki Mishima
- Takashi NakamuraTNTakashi Nakamura
- 1 October 2006
- journal article
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 24 (10) , 2091-2099
Abstract
Effective treatment of obstructive sleep apnoea (OSA) with nasal continuous positive airway pressure (nCPAP) lowers blood pressure (BP). The long-term effects of nCPAP treatment on BP in OSA patients are not well known. The time period of such treatment sufficient to lower BP in OSA patients is also not known. We investigated compliance with long-term nCPAP therapy and its effects on BP. This observational study involved 66 OSA patients [59 men, seven women; mean age, 51 (48–54) years; body mass index (BMI), 28.7 (27.7–29.7) kg/m2; apnoea and hypopnoea, 50.3 (45.6–55.0)/h; 95% confidence intervals]. BP and BMI were measured before the study and at two checkpoints after usage of nCPAP [620 (552–688) and 1071 (1000–1143) days]. The different times between the first and second checkpoints for detecting objective compliance were 17 (4–30) min (P = 0.003). Diastolic BP decreased by 5.9 (3.1–8.7) mmHg after 600 days nCPAP treatment and by 4.6 (2.0–7.2) mmHg after 1000 days (P = 0.0006). Systolic BP and BMI did not change significantly. Usage of nCPAP treatment for a daily average of 3 h was needed to achieve a significant decrease in diastolic BP [7.4 (4.3–10.6) mmHg, P < 0.0001]. Diastolic BP of normotensive OSA patients did not change significantly by nCPAP treatment, but that of hypertensive OSA patients decreased significantly within 1 month–3 years of nCPAP treatment whether or not medication was used. In patients with severe OSA, the use of nCPAP for a daily average of 3 h would be sufficient to decrease the diastolic BP of hypertensive OSA patients.Keywords
This publication has 31 references indexed in Scilit:
- Long-term Effects of Nasal Continuous Positive Airway Pressure Therapy on Cardiovascular Outcomes in Sleep Apnea SyndromeChest, 2005
- Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational studyThe Lancet, 2005
- Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational studyThe Lancet, 2005
- Age-Dependent Associations Between Sleep-Disordered Breathing and HypertensionCirculation, 2005
- Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureHypertension, 2003
- Effect of Continuous Positive Airway Pressure on Blood PressureHypertension, 2000
- Objective patient compliance in long-term use of nCPAPEuropean Respiratory Journal, 1996
- Acceptance and long-term compliance with nCPAP in patients with obstructive sleep apnoea syndromeEuropean Respiratory Journal, 1996
- National High Blood Pressure Education Program Working Group Report on Hypertension in the Elderly. National High Blood Pressure Education Program Working Group.Hypertension, 1994
- Effect of continuous positive airway pressure treatment on daytime function in sleep apnoea/hypopnoea syndromeThe Lancet, 1994